Investors’ data

Latest news

July 12, 2010

THALLION ANNOUNCES 2010 SECOND QUARTER RESULTS

June 24, 2010

THALLION ELIMINATES LONG-TERM LEASE OBLIGATION

June 16, 2010

THALLION PHARMACEUTICALS RECEIVES ARBITRATION DECISION ON TLN-232 LICENSE AGREEMENT

Documentation

Investors Overview

Corporate Office

7150 Alexander-Fleming
Montreal, Quebec
H4S 2C8
Phone: 514-940-3600
Fax: 514-940-3622